Literature DB >> 18541122

Use of complementary and alternative medical therapy by patients with primary brain tumors.

Terri S Armstrong1, Mark R Gilbert.   

Abstract

The use of complementary and alternative medicine (CAM) is increasing. CAM includes mind-body interventions, biologically based therapies, energy therapies, and body-based methods. Primary brain tumors arise within the brain and have a poor prognosis when malignant. Even patients with benign tumors suffer neurologic and systemic symptoms as a result of the tumor or its treatment. CAM is used by 30% of brain tumor patients, who often do not report its use to their physician. Herbal medicines may affect the metabolism of prescribed medications or produce adverse effects that may be attributed to other causes. In patients with systemic cancer, mind-body modalities such as meditation and relaxation therapy have been shown to be helpful in reducing anxiety and pain; acupuncture and hypnotherapy may also reduce both pain and nausea. Recent preclinical studies have reported that ginseng, Scutellaria baicalensis, and Angelica sinensis may promote apoptosis of tumor cells or exercise antiangiogenic effects. Further studies are needed to evaluate the impact of CAM on symptom control or tumor growth in this vulnerable patient population.

Entities:  

Mesh:

Year:  2008        PMID: 18541122     DOI: 10.1007/s11910-008-0040-z

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  33 in total

1.  Angelica sinensis modulates migration and proliferation of gastric epithelial cells.

Authors:  Y N Ye; M W Koo; Y Li; H Matsui; C H Cho
Journal:  Life Sci       Date:  2001-01-12       Impact factor: 5.037

2.  Overview of alternative/complementary medicine.

Authors:  B R Cassileth
Journal:  Cancer Pract       Date:  1998 Jul-Aug

3.  Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. New Approaches to Brain Tumor Therapy Central Nervous System Consortium.

Authors:  M R Fetell; S A Grossman; J D Fisher; B Erlanger; E Rowinsky; J Stockel; S Piantadosi
Journal:  J Clin Oncol       Date:  1997-09       Impact factor: 44.544

4.  Use of complementary therapies in a rural cancer population.

Authors:  M Bennett; C Lengacher
Journal:  Oncol Nurs Forum       Date:  1999-09       Impact factor: 2.172

5.  The prevalence of questionable methods of cancer treatment in the United States.

Authors:  I J Lerner; B J Kennedy
Journal:  CA Cancer J Clin       Date:  1992 May-Jun       Impact factor: 508.702

6.  A mechanistic study of proliferation induced by Angelica sinensis in a normal gastric epithelial cell line.

Authors:  Y N Ye; E S Liu; V Y Shin; M W Koo; Y Li; E Q Wei; H Matsui; C H Cho
Journal:  Biochem Pharmacol       Date:  2001-06-01       Impact factor: 5.858

7.  Effect of polysaccharides from Angelica sinensis on gastric ulcer healing.

Authors:  Y N Ye; H L So; E S L Liu; V Y Shin; C H Cho
Journal:  Life Sci       Date:  2003-01-10       Impact factor: 5.037

8.  Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives.

Authors:  Katsuya Tasaki; Gertraud Maskarinec; Dianne M Shumay; Yvonne Tatsumura; Hisako Kakai
Journal:  Psychooncology       Date:  2002 May-Jun       Impact factor: 3.894

9.  Managing social conflict in complementary and alternative medicine research: the case of antineoplastons.

Authors:  Mitchell R Hammer; Wayne B Jonas
Journal:  Integr Cancer Ther       Date:  2004-03       Impact factor: 3.279

10.  Factors associated with herbal use among urban multiethnic primary care patients: a cross-sectional survey.

Authors:  Grace M Kuo; Sarah T Hawley; L Todd Weiss; Rajesh Balkrishnan; Robert J Volk
Journal:  BMC Complement Altern Med       Date:  2004-12-02       Impact factor: 3.659

View more
  5 in total

1.  Survivorship care planning and implementation in neuro-oncology.

Authors:  Heather Leeper; Kathrin Milbury
Journal:  Neuro Oncol       Date:  2018-11-09       Impact factor: 12.300

2.  Delayed growth of glioma by Scutellaria flavonoids involve inhibition of Akt, GSK-3 and NF-κB signaling.

Authors:  Prahlad Parajuli; N Joshee; S R Chinni; A M Rimando; S Mittal; S Sethi; A K Yadav
Journal:  J Neurooncol       Date:  2010-05-14       Impact factor: 4.130

Review 3.  The effects of beta-glucan on human immune and cancer cells.

Authors:  Godfrey Chi-Fung Chan; Wing Keung Chan; Daniel Man-Yuen Sze
Journal:  J Hematol Oncol       Date:  2009-06-10       Impact factor: 17.388

4.  Pilot randomized, controlled trial of a dyadic yoga program for glioma patients undergoing radiotherapy and their family caregivers.

Authors:  Kathrin Milbury; Jing Li; Shiao-Pei Weathers; Smitha Mallaiah; Terri Armstrong; Yisheng Li; Eduardo Bruera; Lorenzo Cohen
Journal:  Neurooncol Pract       Date:  2018-12-20

5.  Prevalence of complementary and alternative medicine use in brain tumor patients at King Abdulaziz University Hospital, Jeddah, Saudi Arabia.

Authors:  Abdulgadir Atteiah; Azmi Marouf; Rayan Alhazmi; Albaraa Alghamdi; Khalid Almalki; Faisal Albugamy; Soha A Alomar
Journal:  Saudi Med J       Date:  2020-06       Impact factor: 1.484

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.